BriaCell Therapeutics BCTX Stock
BriaCell Therapeutics Price Chart
BriaCell Therapeutics BCTX Financial and Trading Overview
| BriaCell Therapeutics stock price | 3.31 USD |
| Previous Close | 3.64 USD |
| Open | 3.35 USD |
| Bid | 2.38 USD x 200 |
| Ask | 4.1 USD x 200 |
| Day's Range | 3.18 - 3.38 USD |
| 52 Week Range | 2.98 - 36 USD |
| Volume | 741.94K USD |
| Avg. Volume | 225.92K USD |
| Market Cap | 24M USD |
| Beta (5Y Monthly) | 1.629 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -14.42 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BCTX Valuation Measures
| Enterprise Value | -6607147 USD |
| Trailing P/E | N/A |
| Forward P/E | -8.48718 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.7762664 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.216 |
Trading Information
BriaCell Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.629 |
| 52-Week Change | -90.29% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 36 USD |
| 52 Week Low | 2.98 USD |
| 50-Day Moving Average | 4.01 USD |
| 200-Day Moving Average | 7.02 USD |
BCTX Share Statistics
| Avg. Volume (3 month) | 225.92K USD |
| Avg. Daily Volume (10-Days) | 320.73K USD |
| Shares Outstanding | 7.25M |
| Float | 6.41M |
| Short Ratio | 2.16 |
| % Held by Insiders | 0.60% |
| % Held by Institutions | 6.35% |
| Shares Short | 470.16K |
| Short % of Float | 6.48% |
| Short % of Shares Outstanding | 6.47% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | July 31, 2025 |
| Most Recent Quarter (mrq) | January 31, 2026 |
| Next Fiscal Year End | July 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -89.43% |
| Return on Equity (ttm) | -179.20% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -30630110 USD |
| Net Income Avi to Common (ttm) | -29637656 USD |
| Diluted EPS (ttm) | -14.42 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 29.9M USD |
| Total Cash Per Share (mrq) | 4.12 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 10.102 |
| Book Value Per Share (mrq) | 4.264 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -30967316 USD |
| Levered Free Cash Flow (ttm) | -20493214 USD |
Profile of BriaCell Therapeutics
| Country | United States |
| State | BC |
| City | West Vancouver |
| Address | Bellevue Centre |
| ZIP | V7T 2X1 |
| Phone | 604 921 1810 |
| Website | https://briacell.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.
Q&A For BriaCell Therapeutics Stock
What is a current BCTX stock price?
BriaCell Therapeutics BCTX stock price today per share is 3.31 USD.
How to purchase BriaCell Therapeutics stock?
You can buy BCTX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BriaCell Therapeutics?
The stock symbol or ticker of BriaCell Therapeutics is BCTX.
Which industry does the BriaCell Therapeutics company belong to?
The BriaCell Therapeutics industry is Biotechnology.
How many shares does BriaCell Therapeutics have in circulation?
The max supply of BriaCell Therapeutics shares is 8.7M.
What is BriaCell Therapeutics Price to Earnings Ratio (PE Ratio)?
BriaCell Therapeutics PE Ratio is now.
What was BriaCell Therapeutics earnings per share over the trailing 12 months (TTM)?
BriaCell Therapeutics EPS is -14.42 USD over the trailing 12 months.
Which sector does the BriaCell Therapeutics company belong to?
The BriaCell Therapeutics sector is Healthcare.
BriaCell Therapeutics BCTX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
- {{ link.label }} {{link}}